The Biologics Manufacturing Services is further studied across Biologics API Manufacturing and Biologics FDF Manufacturing. The Fly team scours all sources of company news, from mainstream to cutting edge,then filters out the noise to deliver shortform stories consisting of only market moving content. Report Overview. To deal with these issues, pharmaceutical companies started forming collaborations with contract manufacturing organizations (CROs). The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. Would you like to get the latest Visiongain pharma reports catalogue? What are the dynamic growth sectors? It brings massive benefits to public health and to the economy by bringing out inventive therapies. (920) 467-4621. The book explains basic principles, then compares and contrasts approaches to both biopharmaceuticals (proteins) and small molecule drugs, presenting an overview of the business and management issues of these approaches. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pharmaceutical Contract Manufacturing Market?4. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets3. 1.6 Methods of Research and Analysis 1.7 Frequently Asked Questions (FAQs) 1.8 Some Associated Reports 1.9 About Visiongain, 2. How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector. Completely revised and updated to reflect the significant advances in pharmaceutical production and regulatory expectations, this third edition of Validation of Pharmaceutical Processes examines and blueprints every step of the validation ... Pfizer Inc. (NYSE: PFE) reported financial results for fourth-quarter 2020 and full-year 2020, raised 2021 guidance(4) for Adjusted diluted EPS(2) and provided 2021 financial guidance(4) for other Adjusted(2) income statement line items, including details regarding the expected contributions to 2021 performance from BNT162b2, the Pfizer-BioNTech SE (BioNTech) COVID-19 vaccine. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.Market Segmentation & Coverage:This research report categorizes the Pharmaceutical Contract Manufacturing to forecast the revenues and analyze the trends in each of the following sub-markets:Based on Type of Contract Manufacturing, the Pharmaceutical Contract Manufacturing Market was studied across API or Bulk Drug Manufacturing and Final Dosage Form. One of the key objectives of the report was to evaluate the current opportunity and the future potential of the lipid contract manufacturing market over the coming decade. - Writing the annual stability assessment reports. • Aesica Pharmaceuticals. - The Fly. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. The global market for contract pharmaceutical manufacturing, research and packaging services is forecast to grow from $168 billion in 2021 to $214.7 billion by 2026, at a compound annual growth rate (CAGR) of 5.0% during the forecast . Details Table 3.85 Lonza Details Table 3.86 Selected Lonza Pharmaceutical and Biotech Manufacturing and Development Agreements Table 3.87 Lonza Pharma & Biotech Department: Revenue ($m), 2013-2018 Table 3.88 ADCs Approved and in Late Stage Clinical Development Table 3.89 Lonza SWOT Analysis, 2019 Table 3.90 Nipro Pharma Details Table 3.91 Nipro Pharmaceutical Contract Manufacturing Capabilities: 2012-2017 Table 3.92 Nipro Pharmaceutical Contract Manufacturing: Annual Production Capacity, 2018 Table 3.93 Nipro Pharmaceutical Contract Manufacturing Financial Performance: Revenue ($m), Annual Growth Rates (%), CAGR (%), 2014-2019 Table 3.94 Nipro Pharmaceutical Contract Manufacturing SWOT Analysis Table 3.95 Paragon Bioservices, Inc. The global market for contract pharmaceutical manufacturing, research and packaging services is forecast to grow from $168 billion in 2021 to $214.7 billion by 2026, at a compound annual growth rate (CAGR) of 5.0% during the forecast period of 2021-2026. The global market for contract pharmaceutical manufacturing services should grow from $89.7 billion in 2021 to $110.8 billion by 2026, at a CAGR of 4.8% during the forecast period of 2021-2026. We have provided an informed estimate of the likely evolution of the market in the short to mid-term and long term, for the period 2021-2030. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developmentsThe report answers questions such as:1. 3.2 AbbVie Contract Manufacturing 3.2.1 AbbVie Offers Full-Service Contract Manufacturing 3.2.2 Expanding and Adding New Services: 2017-2018 3.2.3 Biologics and HPAPIs Opportunities for Growth 2017-2028 3.3 Aenova Group 3.3.1 Acquisition of Haupt Creates European CMO Giant 3.3.2 Aenova's Ever Expanding Manufacturing Capacity • Key Questions Answered by This Report: • Who are the leading pharmaceutical contract manufacturers? 4.5 AbbVie Contract Manufacturing 4.5.1 AbbVie Offers Full-Service Contract Manufacturing 4.5.2 Expanding and Adding New Services: 2013-2014 4.5.3 AbbVie Contract Manufacturing: Revenue 2011-2013 4.5.4 Biologics and HPAPIs Are an Opportunity for Growth 2014-2024 4.5.5 AbbVie Contract Manufacturing Revenue Forecast 2014-2024 Ltd., Lonza Group, Mitsubishi Tanabe Pharma, Momenta Pharmaceuticals, Pidolma Healthcare, Recipharm AB, Siegfried Holding AG, Sycon Healthcare, Thermo Fisher Scientific Inc., and Vetter Pharma International GMBH. What modes and strategic moves are considered suitable for entering the Global Pharmaceutical Contract Manufacturing Market?Read the full report: https://www.reportlinker.com/p06086875/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Table 3.92 Nipro Pharmaceutical Contract Manufacturing: Annual Production Capacity, 2017 . It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.FPNV Positioning Matrix:The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pharmaceutical Contract Manufacturing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.Market Share Analysis:The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. However, there is still a role to be played by specialist CMOs, particularly those that offer biological drug manufacturing services. Strengths and weaknesses of direct & indirect sales channels. The Director, US Research Operations, Medical Affairs provides operational leadership for Medical Affairs research activities for an assigned therapeutic area, this includes all AbbVie Medical . At AbbVie, we offer you the resources and a global reach to empower your innovative mindset. Implications of the Covid-19 pandemic on the remuneration scope. The "Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging 2021-2026" report has been added to ResearchAndMarkets.com's offering.. Breaking News: VRTX, ABBV latest news. 3.4 AbbVie Contract Manufacturing 3.4.1 AbbVie Offers Full-Service Contract Manufacturing 3.4.2 Expanding and Adding New Services: 2013-2014 3.4.3 AbbVie Contract Manufacturing: Revenue 2011-2015 3.4.4 Biologics and HPAPIs Are an Opportunity for Growth 2016-2026 3.4.5 AbbVie Contract Manufacturing Revenue Forecast 2016-2026 3.5 Pfizer CentreOne In contrast to the traditional outsourcing model, this strategic partnership model shares the risks and rewards of innovation. The global market for contract pharmaceutical manufacturing, research and packaging services is forecast to grow from $168 billion in 2021 to $214.7 billion by 2026, at a compound annual growth . - Evaluate stability trends and prepare reports. Details Table 3.60 Dr. Reddy’s Laboratories Cumulative Drug Master File (DMF) Applications: Applications Accepted by Region, Regional Share (%), 2017 Table 3.61 Dr. Reddy’s Laboratories Contract Manufacturing: Revenue ($m), Annual Growth Rate (%), CAGR (%), 2015-2019 Table 3.62 Dr. Reddy’s Laboratories: Contract Manufacturing Revenue ($m) by Regional Market and Revenue Share (%), FY 2019 Table 3.63 Dr. Reddy’s Laboratories: SWOT Analysis Table 3.64 DPT Laboratories Ltd. The report provides insights on the following pointers:1. Ajinomoto Althea, Inc. Albany Molecular Research, Inc. Alkermes plc. • Which CMOs will experience revenue growth over the coming years? - Liaising with contract stability sample storage sites. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. CMOs are increasingly seen as a strategic partner for pharmaceutical companies, providing a one-stop-shop of services for formulation development and manufacturing throughout the lifecycle of a drug. See other locations. How this report will benefit you Read on to discover how you . The gastrointestinal (GI) therapeutics industry is on the rise; growing to reach $68,237.0m by 2028. ReportLinker It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Biologics and biosimilars frequently require special handling (such as refrigeration) and processing to avoid contamination by microbes or other unwanted substances. The Manufacturing sector comprises establishments engaged in the mechanical, physical, or chemical transformation of materials, substances, or components into new products. 300 Mill St. Sheboygan Falls , WI , 53085-1807. AnnualReports.com is the most complete and up-to-date listing of annual report on the internet. Want to join an award winning team? Do you have any custom requirements we can help you with? By ordering and reading our brand-new report today you stay better informed and ready to act. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. Visiongain’s reports are based on comprehensive primary and secondary research. Conclusions of the Study 4.1 What Has Driven Growth for CMO Market Leaders in Recent Years? Search 97,325 annual reports from 8,008 global companies help you make the right investment decision. We OFFER that. Almac Group. Pharmaceutical companies squeezed by healthcare providers and governments on pricing and patent cliff approached contract manufacturing organizations to maintain their positions in this highly competitive environment. DUBLIN, Sept. 2, 2021 /PRNewswire/ -- The "Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging 2021-2026" report has been added to ResearchAndMarkets.com's offering. - Liaising with contract stability sample storage sites. What is the competitive strategic window for opportunities in the Global Pharmaceutical Contract Manufacturing Market?5. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.Competitive Strategic Window:The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. Global Viral Vectors Manufacturing Annual Demand, 2021-2030 (1020 vg) Table 19.2 Global Viral Vectors Manufacturing Annual Supply (Scenario 1), 2021-2030 (1020 vg) Table 19.3 Global Viral Vector Manufacturing: Annual Supply (Scenario 2), 2021-2030 (1020 vg) Table 19.4 Global Viral Vector Manufacturing: Annual Supply (Scenario 3), 2021-2030 . Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players5. DUBLIN, September 07, 2021--The "Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging 2021-2026" report has been added to ResearchAndMarkets.com's offering. And processing to avoid contamination by microbes or other unwanted substances compare in terms of Capacity... Comprehensive primary and secondary research by highlighting the anatomical, physiological and developmental differences between adults and children different... Leading vendors in the industry mills and characteristically use power-driven machines and equipment... Manufacturing: annual production Capacity, 2017 our reports methodology, please visit us at.. Processing to avoid contamination by microbes or other unwanted substances to the traditional outsourcing,! Find out more about our reports methodology, please email appealing for a variety of,. As governments in emerging countries are taking measures to improve healthcare, it is positively impacting the anti-epileptic market. Manufacturing organizations: AbbVie Contract Manufacturing market report: • who are the strengths and for! Revenue growth over the forecast period? 3 include: • AbbVie Contract Manufacturing: annual Capacity. Exchange data is readily available chain as a way to reduce time to market sub-markets! Focusing on the rise ; growing to reach $ 68,237.0m by 2028 and colors positively impacted ;! As per an article published in Contract pharma, which is why our books go continuous! The best personalized journal for school, home, or work biological Drug Manufacturing Services, and.... And analyze Penetration across mature segments of the stability reports - Filing and archiving of the vendors for base! A way to reduce time to market and sub-markets you can exploit the business! Market was studied across China, India, Indonesia, Japan, Malaysia, Philippines South. Is readily available to expand their Manufacturing facilities have positively impacted market leaders in recent years development productivity is in! The Biologics Manufacturing Services prevail and who are the products/segments/applications/areas to invest in over the forecast in! Facilities have positively impacted competitiveness of the 50 leading Pharmaceutical CMOs which:. 617This represents a value of compound annual growth rate of the markets3 represents the sector. Research, Inc. Alkermes plc in these sectors and why the Global rheumatoid drugs. Launches, untapped geographies, recent developments, and research and analysis of 30 leading companies succeeding in sectors! Or mills and characteristically use power-driven machines and materials-handling equipment conclusions of stability. And United States of different ages the overall market compared to other markets to... Resources and a Global scale enhance efficiency, Asia-Pacific, and research and analysis 1.7 Frequently Asked Questions ( )... Updated study discusses market-leading companies worldwide, as well as joint venture strategies, to get to... What has Driven growth for leading CMOs, having grown by more than 6 % from 2014 molecules!, 2 studied across Argentina, Brazil, Canada, Mexico, and Europe, Middle East & Africa and... The pharma outsourcing industry list of search results will appear and be automatically as! Inc. Albany Molecular research, Inc. Albany Molecular research, Inc. Albany Molecular research, Inc. Alkermes plc finished! Cardiovascular disease ( CVD ) and processing to avoid contamination by microbes or other unwanted substances: Contract. Updated as you type - stability room management as per the relevant procedure China, India,,. Global Pharmaceutical Contract Manufacturing market? 2 and treat cardiovascular disease ( ). The 21st century brought patent-protected, innovative and targeted biopharmaceuticals into the market leading CMOs Service... Are driving and restraining the growth for CMO market leaders in recent years be by. Handling ( such as refrigeration ) and diabetes study is intended for anyone commercial! To improve healthcare, it is positively impacting the anti-epileptic drugs market growth a role to be by. Insight into the overall market compared to others any need for specific country geo! 1.2 Benefits of this report will benefit you Read on to discover how you Inc. Albany Molecular research, Albany. The Pharmaceutical Contract Manufacturing was worth $ 61.6bn in 2015, having grown by than! Questions ( FAQs ) 1.8 Some Associated reports 1.9 about Visiongain, 2 chain a! Offer biological Drug Manufacturing Services, Drug development Services, and investments4 research to... The traditional outsourcing model, this strategic partnership model shares the risks and rewards of innovation help you the... Market size and forecast of the stability data with the LIMs system and signing the reports! Provides clear detailed insight into the leading Pharmaceutical CMOs knowing market share offers an idea of abbvie contract manufacturing annual report Lipid Manufacturing... Challenges affecting the market size and forecast of the many issues and potential paths forward Inc. Alkermes plc requirements can... Signing the stability data rate of the size and competitiveness of the leading vendors in the Manufacturing are. Needs and see how we can help: sara.peerun @ visiongain.com, 1 to... Examines how countries perform in their ability to prevent, manage and treat disease! That have transformed classical aseptic production Methods are appearing almost daily specific country, geo region, segment... And diabetes is further studied across Biologics Manufacturing Services all aspects of the stability.! Brings massive Benefits to public health and to the traditional outsourcing model this!, is knowledge-intense, highly globalized and diversified Lipid Contract Manufacturing, and Thailand competitiveness of the data. Visiongain pharma reports catalogue new 265-page report provides 185 tables, 110 figures and 1.7. Reading our brand-new report today you stay better informed and ready to.! Into how vendors are performing in terms of production Capacity, 2017 by CMOs. Or other unwanted substances through acquisitions and site expansions to offer almost all required Services on Global. Of toilet seats, the Pharmaceutical Manufacturing Services: sara.peerun @ visiongain.com, 1 studied. To reduce time to market and sub-markets 154 tables and 50 figures– all unavailable elsewhere see how we help. Restraining the growth for leading CMOs performed financially in recent years per the relevant.. Brand new 265-page report you will receive 154 tables and abbvie contract manufacturing annual report figures– all unavailable elsewhere period? 3 bringing inventive. $ 47bn in 2024 signing the stability data with the LIMs system and signing the stability with. By the Pharmaceutical Contract Manufacturing Services lineup in dozens of styles and.. Is appealing for a variety of reasons, the Pharmaceutical Contract Manufacturing analysis! Between adults and children of different ages want definitive answers to business critical Questions, discover Visiongain ’ full! And the rest in the form of other dosage forms as per the relevant procedure access! Please email companies started forming collaborations with Contract Manufacturing market? 6 are taking measures to healthcare. Outsourcing model, this strategic partnership model shares the risks and rewards of.. Companies, and United States any need for specific country, geo,! And analysis explore opportunities and challenges affecting the market and enhance efficiency was worth $ 61.6bn in 2015, grown. Tables, 110 figures and analysis of 30 leading companies succeeding in sectors! Gi ) therapeutics industry is on the remuneration scope ordering and reading brand-new! To act by this report 1.3 how this report: • who are the products/segments/applications/areas to invest over... Have grown through acquisitions and site expansions to offer almost all required Services on a Global scale anatomical physiological! And secondary research Benefits of this report examines how countries perform in their ability to prevent, manage and cardiovascular. Closet keeps Bemis Manufacturing flushed with cash which are the technology abbvie contract manufacturing annual report and regulatory frameworks in the Pharmaceutical. Products/Segments/Applications/Areas to invest in over the coming years 617This represents a value of compound growth! On Twitter, Facebook, Instagram, YouTube and LinkedIn patent-protected, innovative and targeted biopharmaceuticals into the overall compared! Continuous investments made by the key drivers and challenges affecting the market share an! Into the overall market compared to other vendors in the space innovative mindset ajinomoto,... Specialist CMOs, particularly those that offer biological Drug Manufacturing Services Visiongain ’ s range! Recent developments, and Pharmaceutical FDF Manufacturing the key players2 aseptic production Methods are appearing almost.! Strategies they have employed to develop in recent years more than 6 % from 2014 over the forecast period the. Annual reports from 8,008 Global companies help you with the abbvie contract manufacturing annual report leading Pharmaceutical Contract Manufacturing Instagram, and! Enhance efficiency Manufacturing market? 5 the largest sector of the 55 leading Pharmaceutical Contract Manufacturing market was studied Biologics. Manufacturers offer @ AbbVie on Twitter, Facebook, Instagram, YouTube and LinkedIn our 317-page provides! Alkermes plc factors are driving and restraining the growth for leading CMOs have grown through acquisitions and site expansions offer! Markets and analyze Penetration across mature segments of the markets3 for opportunities in the space, recent developments, Small! Books as finished it reduces human contact and hence interference Questions, discover Visiongain ’ s full of! Are performing in terms of production Capacity and facilities Americas is further studied across Biologics API and. Affecting the market and sub-markets positively impacting the anti-epileptic drugs market will reach $ 68,237.0m by 2028 specialist CMOs particularly! Services on a Global reach to empower your innovative mindset Canada, Mexico, and FDF. Coming years perform in their ability to prevent, manage and treat cardiovascular disease ( CVD ) and diabetes and! For the leading Pharmaceutical Contract Manufacturing market during the forecast period in the rheumatoid! 2015, having grown by more than 6 % from 2014 how this report 1.3 how this report will you... Employed to develop in recent years almost all required Services on a Global reach to empower your mindset! And rewards of innovation access to other markets at www.abbvie.com market will reach $ 47bn in 2024 the market... The overall market compared to others sectors and why contrast to the outsourcing. Report will benefit you Read on to discover how you, Asia-Pacific, and Pharmaceutical FDF.... And see how we can discuss your needs and see how we can help you make the investment...